No association between endogenous retinoic acid and human papillomavirus clearance or incident cervical lesions in Brazilian Women

Cancer Prevention Research

Volumn 3, Issue 8, 2010, Pages 1007-1014

  Siegel, Erin M ^a   Salemi, Jason L ^b   Craft, Neal E ^c   Villa, Luisa L ^d   Ferenczy, Alex S ^e   Franco, Eduardo L ^e   Giuliano, Anna R ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Craft Technologies Inc   (United States)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; BRAZIL; CANCER RISK; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM CELL; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOMER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER; UTERINE CERVIX DISEASE; UTERINE CERVIX EPITHELIUM; VIRUS INFECTION; VIRUS INHIBITION; WART VIRUS;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; BIOLOGICAL TRANSPORT; BRAZIL; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; TRETINOIN; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD; YOUNG ADULT;

EID: 77955436740     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0239     Document Type: Article

References (40)

1. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
2. Kanodia S, Fahey LM, Kast WM. Mechanisms used by human papillomaviruses to escape the host immune response. Curr Cancer Drug Targets 2007;7:79-89.
3. von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 2002;38:2229-42.
4. Niles RM. Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer. Nutrition 2000;16:1084-9.
5. Abu J, Batuwangala M, Herbert K, Symonds P. Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer. Lancet Oncol 2005;6:712-20.
6. Ross AC, Zolfaghari R, Weisz J, Vitamin A. Recent advances in the biotransformation, transport, and metabolism of retinoids. Curr Opin Gastroenterol 2001;17:184-92.
7. Napoli JL. Interactions of retinoid binding proteins and enzymes in retinoid metabolism. Biochim Biophys Acta 1999;1440:139-62.
8. Heyman RA, Mangelsdorf DJ, Dyck JA, et al. 9-cis Retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992;68: 397-406.
9. Blaner WS. Cellular metabolism and actions of 13-cis-retinoic acid. J Am Acad Dermatol 2001;45:S129-35.
10. Agarwal C, Rorke EA, Irwin JC, Eckert RL. Immortalization by human papillomavirus type 16 alters retinoid regulation of human ectocervical epithelial cell differentiation. Cancer Res 1991;51:3982-9.
11. Narayanan BA, Holladay EB, Nixon DW, Mauro CT. The effect of all-trans and 9-cis retinoic acid on the steady state level of HPV16 E6/E7 mRNA and cell cycle in cervical carcinoma cells. Life Sci 1998;63: 565-73.
12. Faluhelyi Z, Rodler I, Csejtey A, Tyring SK, Ember IA, Arany I. All-trans retinoic acid (ATRA) suppresses transcription of human papillomavirus type 16 (HPV16) in a dose-dependent manner. Anticancer Res 2004;24:807-9.
13. Khan MA, Jenkins GR, Tolleson WH, Creek KE, Pirisi L. Retinoic acid inhibition of human papillomavirus type 16-mediated transformation of human keratinocytes. Cancer Res 1993;53:905-9.
14. Creek KE, Jenkins GR, Khan MA, et al. Retinoic acid suppresses human papillomavirus type 16 (HPV16)-mediated transformation of human keratinocytes and inhibits the expression of the HPV16 oncogenes. Adv Exp Med Biol 1994;354:19-35.
15. Giuliano AR. The role of nutrients in the prevention of cervical dysplasia and cancer. Nutrition 2000;16:570-3.
16. Meyskens FL, Jr., Surwit E, Moon TE, et al. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst 1994;86:539-43.
17. Ruffin MT, Bailey JM, Normolle DP, et al. Low-dose topical delivery of all-trans retinoic acid for cervical intraepithelial neoplasia II and III. Cancer Epidemiol Biomarkers Prev 2004;13:2148-52.
18. Alvarez RD, Conner MG, Weiss H, et al. The efficacy of 9-cis-retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: results of a randomized double-blind clinical trial. Cancer Epidemiol Biomarkers Prev 2003;12:114-9.
19. Kim SH, Park TK, Kwon JY. 13-cis-Retinoic acid for chemoprevention after colpoconization for cervical intraepithelial neoplasia. Int J Gynaecol Obstet 2003;81:217-8.
20. Robinson WR, Andersen J, Darragh TM, Kendall MA, Clark R, Maiman M. Isotretinoin for low-grade cervical dysplasia in human immunodeficiency virus-infected women. Obstet Gynecol 2002;99: 777-84.
21. Follen M, Atkinson EN, Schottenfeld D, et al. A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix. Clin Cancer Res 2001;7:3356-65.
22. Berlin Grace VM, Niranjali Devaraj S, Radhakrishnan Pillai M, Devaraj H. HPV-induced carcinogenesis of the uterine cervix is associated with reduced serum ATRA level. Gynecol Oncol 2006;103:113-9.
23. Siegel EM, Craft NE, Roe DJ, et al. Temporal variation and identification of factors associated with endogenous retinoic acid isomers in serum from Brazilian women. Cancer Epidemiol Biomarkers Prev 2004;13:1693-703.
24. Giuliano AR, Siegel EM, Roe DJ, et al. Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV natural history study. J Infect Dis 2003;188:1508-16.
25. Siegel EM, Craft NE, Duarte-Franco E, Villa LL, Franco EL, Giuliano AR. Associations between serum carotenoids and tocopherols and type-specific HPV persistence: the Ludwig-McGill cohort study. Int J Cancer 2007;120:672-80.
26. Franco E, Villa L, Rohan T, Ferenczy A, Petzl-Erler M, Matlashewski G. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group. Rev Panam Salud Publica 1999;6:223-33.
27. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. Developed and approved at the National Cancer Institute Workshop, Bethesda, Maryland, December 12-13, 1988. Acta Cytol 1989;33:567-74.
28. Resnick RM, Cornelissen MT, Wright DK, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990;82:1477-84.
29. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265:472-7.
30. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-7.
31. Bernard HU, Chan SY, Manos MM, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994;170:1077-85.
32. Horst RL, Reinhardt TA, Goff JP, et al. Identification of 9-cis,13-cisretinoic acid as a major circulating retinoid in plasma. Biochemistry 1995;34:1203-9.
33. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007;90:1-636.
34. Sedjo RL, Roe DJ, Abrahamsen M, et al. Vitamin A, carotenoids, and risk of persistent oncogenic human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2002;11:876-84.
35. Goodman MT, Kiviat N, McDuffie K, et al. The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii. Cancer Epidemiol Biomarkers Prev 1998;7:537-44.
36. Palan PR, Mikhail MS, Goldberg GL, Basu J, Runowicz CD, Romney SL. Plasma levels of β-carotene, lycopene, canthaxanthin, retinol, and α- and τ-tocopherol in cervical intraepithelial neoplasia and cancer. Clin Cancer Res 1996;2:181-5.
37. Kwasniewska A, Tukendorf A, Semczuk M. Content of β-carotene in blood serum of human papillomavirus infected women with cervical dysplasias. Arch Immunol Ther Exp (Warsz) 1996;44:309-13.
38. Potischman N, Hoover RN, Brinton LA, et al. The relations between cervical cancer and serological markers of nutritional status. Nutr Cancer 1994;21:193-201.
39. Helm CW, Lorenz DJ, Meyer NJ, Rising WR, Wulff JL. Retinoids for preventing the progression of cervical intra-epithelial neoplasia. Cochrane Database of Syst Rev 2007;(4), CD003296. http://mrw.interscience.wiley.com/ cochrane/clsysrev/articles/CD003296/frame.html.
40. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-9.